Re: Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. 2023;84:4-6

Affiliations

¹ Garvan Institute of Medical Research, Sydney, Australia; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia; St. Vincent's Clinical School, University of New South Wales, Darlinghurst, Australia.
² Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA.
³ Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland; Division of Cancer Sciences, University of Manchester, Manchester, UK.
⁴ Garvan Institute of Medical Research, Sydney, Australia; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia; St. Vincent's Clinical School, University of New South Wales, Darlinghurst, Australia. Electronic address: anthony.joshua@svha.org.au.

Comment

Luke C Ardolino et al. Eur Urol. 2023 Oct.

. 2023 Oct;84(4):e94-e95.

doi: 10.1016/j.eururo.2023.04.043. Epub 2023 Jun 22.

¹ Garvan Institute of Medical Research, Sydney, Australia; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia; St. Vincent's Clinical School, University of New South Wales, Darlinghurst, Australia.
² Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA.
³ Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland; Division of Cancer Sciences, University of Manchester, Manchester, UK.
⁴ Garvan Institute of Medical Research, Sydney, Australia; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia; St. Vincent's Clinical School, University of New South Wales, Darlinghurst, Australia. Electronic address: anthony.joshua@svha.org.au.

No abstract available

Comment on

Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial.
Olivier T, Powell K, Prasad V. Olivier T, et al. Eur Urol. 2023 Jul;84(1):4-6. doi: 10.1016/j.eururo.2022.08.022. Epub 2022 Sep 9. Eur Urol. 2023. PMID: 36096857
Reply to Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.022.
Morris MJ, Sartor O, de Bono JS, Fizazi K, Tagawa ST. Morris MJ, et al. Eur Urol. 2023 Jul;84(1):7-8. doi: 10.1016/j.eururo.2023.03.028. Epub 2023 Apr 7. Eur Urol. 2023. PMID: 37032186 No abstract available.